Spark Therapeutics (ONCE) PT Lowered to $60 at Chardan Capital Markets
Tweet Send to a Friend
Chardan Capital Markets analyst Gbola Amusa lowered its price target on Spark Therapeutics (NASDAQ: ONCE) to $60.00 (from $100.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
